Vaxart, Inc. (VXRT) financial statements (2021 and earlier)

Company profile

Business Address 290 UTAH AVE., SUITE 200
SOUTH SAN FRANCISCO, CA 94080
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
6/30/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments14123969588267
Cash and cash equivalents14121850458267
Short-term investments  211913  
Receivables4211252011
Prepaid expense      13
Contract with customer, asset0 
Other undisclosed current assets0113(12)(0)(11)
Total current assets:181540727110180
Noncurrent Assets
Operating lease, right-of-use asset2
Property, plant and equipment0100024
Long-term investments and receivables    810 
Long-term investments    810 
Intangible assets, net (including goodwill)1719   1
Intangible assets, net (excluding goodwill)1719    1
Other noncurrent assets00    
Deferred tax assets, net   11 
Total noncurrent assets:1921009134
TOTAL ASSETS:373540737911484
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:524882615
Accounts payable1114234
Accrued liabilities5234538
Employee-related liabilities    202
Other undisclosed accounts payable and accrued liabilities    (1)19 
Debt1 000  
Deferred revenue and credits11  0
Deferred tax liabilities   11 
Other undisclosed current liabilities35    1
Total current liabilities:976992716
Noncurrent Liabilities
Long-term debt and lease obligation12001  
Long-term debt, excluding current maturities 2001  
Operating lease, liability1
Liabilities, other than long-term debt0015170(1)0
Deferred revenue and credits1517   
Deferred tax liabilities, net    (1) 
Other liabilities0000000
Other undisclosed noncurrent liabilities1314   1 
Total noncurrent liabilities:15171617100
Total liabilities:24242127102716
Stockholders' equity
Stockholders' equity attributable to parent13111946708768
Common stock5144443
Additional paid in capital125109160158156146119
Accumulated other comprehensive income  1919192725
Accumulated deficit(117)(98)(164)(134)(109)(90)(79)
Total stockholders' equity:13111946708768
TOTAL LIABILITIES AND EQUITY:373540737911484

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
6/30/2013
Revenues10499256934
Revenue, net69256934
Cost of revenue
(Cost of Goods and Services Sold)
    (4)(51)(20)
Gross profit:10499211813
Operating expenses(26)(26)(36)(35)(54)(90)(74)
Other undisclosed operating income    136138
Operating loss:(16)(22)(28)(25)(20)(12)(22)
Nonoperating income (expense)(2)4(2)(0)002
Investment income, nonoperating 7     
Foreign currency transaction gain (loss), before tax(0)(0)  7(1)2
Other nonoperating income  000  
Interest and debt expense(0)(1)     
Other undisclosed income from continuing operations before equity method investments, income taxes01     
Loss from continuing operations before equity method investments, income taxes:(18)(18)(29)(25)(19)(11)(20)
Other undisclosed income from continuing operations before income taxes      12
Loss from continuing operations before income taxes:(18)(18)(29)(25)(19)(11)(9)
Income tax expense (benefit)(0)(0)(0) 00(0)
Net loss attributable to parent:(19)(18)(29)(25)(19)(11)(9)
Preferred stock dividends and other adjustments (0)     
Net loss available to common stockholders, diluted:(19)(18)(29)(25)(19)(11)(9)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
6/30/2013
Net loss:(19)(18)(29)(25)(19)(11)(9)
Comprehensive loss:(19)(18)(29)(25)(19)(11)(9)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent   0(8)2(4)
Comprehensive loss, net of tax, attributable to parent:(19)(18)(29)(25)(27)(10)(13)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: